HistoSonics announced today that it received CE mark approval for its Edison non-invasive histotripsy technology platform.

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms, changes begin to unfold inside the liver. While hepatic fat accumulation ...

Patients with colorectal cancer (CRC) liver metastases had reduced risk of intrahepatic recurrence when using intraoperative contrast-enhanced ultrasounds. A new study published in Digestive and Liver ...

Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve its prognosis and patient ...

Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound waves. For some patients with liver cancer, they could be spared invasive ...

Portal hypertension (PH), a serious complication of liver cirrhosis, is defined as a pressure gradient > 5 mmHg between the portal vein and the inferior vena cava. When the hepatic venous pressure ...

A new ultrasound-guided nanotherapy wipes out liver tumors while training the immune system to keep them from coming back. Study: Sonodynamic biodegradable pseduo-conjugate polymer delivery of ...

The technology has some promising applications, but is not ready for whole body cancer screening and will not replace other ...

Grade 1 fatty liver is often silent, but it should not be ignored. Doctors say early lifestyle changes can reverse the ...

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective ...